Low-Dose IL-2 Lowers Arterial Inflammation and Trends Towards Lower MACE in patients with ACS: The results of the IVORY trial and IVORY FINALE study
Sriranjan Rouchelle, Templin Heike, Brubert Jacob, Krishnan Unni, O'brien James, Rudd James, Cheriyan Joseph, Mallat Ziad, Zhao Tian, Hoole Stephen, Bond Simon, Tarkin Jason, Hubsch Annette, Helmy Joanna, Bumanlag-amis Elaine, Jalaludeen Navazh